Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001130319-06-000924
Filing Date
2006-11-09
Accepted
2006-11-09 13:57:52
Documents
2
Period of Report
2011-09-06

Document Format Files

Seq Description Document Type Size
1 ONCOLYTICS BIOTECH INC. REPORTS REOLYSIN AND CHEMOTHERAPEUTIC AGENTS ARE SYNERGI o33719form6vk.htm 6-K 16567
2 GRAPHIC o33719o3371900.gif GRAPHIC 2229
  Complete submission text file 0001130319-06-000924.txt   21212
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-31062 | Film No.: 061201037
SIC: 2834 Pharmaceutical Preparations